rs4647946

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001004356.3(FGFRL1):​c.891T>C​(p.Asp297Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0394 in 1,612,472 control chromosomes in the GnomAD database, including 1,546 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.034 ( 135 hom., cov: 33)
Exomes 𝑓: 0.040 ( 1411 hom. )

Consequence

FGFRL1
NM_001004356.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.84

Publications

2 publications found
Variant links:
Genes affected
FGFRL1 (HGNC:3693): (fibroblast growth factor receptor like 1) The protein encoded by this gene is a member of the fibroblast growth factor receptor (FGFR) family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein would consist of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. A marked difference between this gene product and the other family members is its lack of a cytoplasmic tyrosine kinase domain. The result is a transmembrane receptor that could interact with other family members and potentially inhibit signaling. Multiple alternatively spliced transcript variants encoding the same isoform have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 4-1024483-T-C is Benign according to our data. Variant chr4-1024483-T-C is described in ClinVar as Benign. ClinVar VariationId is 1170810.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.85 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.109 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FGFRL1NM_001004356.3 linkc.891T>C p.Asp297Asp synonymous_variant Exon 6 of 7 ENST00000510644.6 NP_001004356.1 Q8N441A0PJ49

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FGFRL1ENST00000510644.6 linkc.891T>C p.Asp297Asp synonymous_variant Exon 6 of 7 1 NM_001004356.3 ENSP00000425025.1 Q8N441
FGFRL1ENST00000264748.6 linkc.891T>C p.Asp297Asp synonymous_variant Exon 5 of 6 1 ENSP00000264748.6 Q8N441
FGFRL1ENST00000504138.5 linkc.891T>C p.Asp297Asp synonymous_variant Exon 6 of 7 1 ENSP00000423091.1 Q8N441
FGFRL1ENST00000398484.6 linkc.891T>C p.Asp297Asp synonymous_variant Exon 7 of 8 5 ENSP00000381498.2 Q8N441

Frequencies

GnomAD3 genomes
AF:
0.0339
AC:
5162
AN:
152106
Hom.:
132
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0122
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.0337
Gnomad ASJ
AF:
0.0467
Gnomad EAS
AF:
0.117
Gnomad SAS
AF:
0.0178
Gnomad FIN
AF:
0.0476
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0391
Gnomad OTH
AF:
0.0536
GnomAD2 exomes
AF:
0.0389
AC:
9614
AN:
246846
AF XY:
0.0379
show subpopulations
Gnomad AFR exome
AF:
0.0109
Gnomad AMR exome
AF:
0.0203
Gnomad ASJ exome
AF:
0.0431
Gnomad EAS exome
AF:
0.116
Gnomad FIN exome
AF:
0.0515
Gnomad NFE exome
AF:
0.0401
Gnomad OTH exome
AF:
0.0419
GnomAD4 exome
AF:
0.0400
AC:
58417
AN:
1460248
Hom.:
1411
Cov.:
33
AF XY:
0.0394
AC XY:
28631
AN XY:
726442
show subpopulations
African (AFR)
AF:
0.0103
AC:
344
AN:
33476
American (AMR)
AF:
0.0215
AC:
961
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.0398
AC:
1040
AN:
26104
East Asian (EAS)
AF:
0.113
AC:
4498
AN:
39694
South Asian (SAS)
AF:
0.0138
AC:
1188
AN:
86248
European-Finnish (FIN)
AF:
0.0529
AC:
2753
AN:
52054
Middle Eastern (MID)
AF:
0.0270
AC:
156
AN:
5768
European-Non Finnish (NFE)
AF:
0.0403
AC:
44858
AN:
1111844
Other (OTH)
AF:
0.0434
AC:
2619
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
3928
7856
11783
15711
19639
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1730
3460
5190
6920
8650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0340
AC:
5179
AN:
152224
Hom.:
135
Cov.:
33
AF XY:
0.0343
AC XY:
2553
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.0123
AC:
512
AN:
41550
American (AMR)
AF:
0.0336
AC:
515
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0467
AC:
162
AN:
3472
East Asian (EAS)
AF:
0.117
AC:
604
AN:
5162
South Asian (SAS)
AF:
0.0178
AC:
86
AN:
4830
European-Finnish (FIN)
AF:
0.0476
AC:
505
AN:
10608
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0391
AC:
2655
AN:
67978
Other (OTH)
AF:
0.0597
AC:
126
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
270
540
810
1080
1350
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0359
Hom.:
48
Bravo
AF:
0.0333
Asia WGS
AF:
0.0790
AC:
275
AN:
3478
EpiCase
AF:
0.0407
EpiControl
AF:
0.0401

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

FGFRL1-related disorder Benign:1
Feb 23, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.69
DANN
Benign
0.63
PhyloP100
-1.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4647946; hg19: chr4-1018271; API